Engineers Gate Manager’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Sell |
16,468
-6,011
| -27% | -$63.6K | ﹤0.01% | 1921 |
|
|
2025
Q1 | $338K | Sell |
22,479
-9,474
| -30% | -$142K | 0.01% | 1646 |
|
|
2024
Q4 | $526K | Buy |
31,953
+18,065
| +130% | +$297K | 0.01% | 1383 |
|
|
2024
Q3 | $343K | Sell |
13,888
-7,887
| -36% | -$195K | 0.01% | 1566 |
|
|
2024
Q2 | $552K | Sell |
21,775
-6,123
| -22% | -$155K | 0.01% | 1176 |
|
|
2024
Q1 | $709K | Buy |
27,898
+814
| +3% | +$20.7K | 0.02% | 1017 |
|
|
2023
Q4 | $614K | Buy |
27,084
+2,562
| +10% | +$58.1K | 0.02% | 1069 |
|
|
2023
Q3 | $457K | Buy |
+24,522
| New | +$457K | 0.02% | 1097 |
|
|
2022
Q3 | – | Sell |
-25,816
| Closed | -$576K | – | 1592 |
|
|
2022
Q2 | $576K | Buy |
+25,816
| New | +$576K | 0.02% | 1036 |
|
|
2021
Q3 | – | Sell |
-12,531
| Closed | -$542K | – | 1616 |
|
|
2021
Q2 | $542K | Sell |
12,531
-6,139
| -33% | -$266K | 0.03% | 785 |
|
|
2021
Q1 | $762K | Buy |
18,670
+3,660
| +24% | +$149K | 0.04% | 723 |
|
|
2020
Q4 | $679K | Sell |
15,010
-2,486
| -14% | -$112K | 0.03% | 790 |
|
|
2020
Q3 | $619K | Sell |
17,496
-3,910
| -18% | -$138K | 0.03% | 869 |
|
|
2020
Q2 | $808K | Buy |
21,406
+1,231
| +6% | +$46.5K | 0.04% | 696 |
|
|
2020
Q1 | $583K | Buy |
20,175
+13,339
| +195% | +$385K | 0.04% | 683 |
|
|
2019
Q4 | $354K | Sell |
6,836
-5,646
| -45% | -$292K | 0.02% | 1173 |
|
|
2019
Q3 | $685K | Sell |
12,482
-8,010
| -39% | -$440K | 0.03% | 665 |
|
|
2019
Q2 | $832K | Sell |
20,492
-8,931
| -30% | -$363K | 0.05% | 569 |
|
|
2019
Q1 | $890K | Buy |
+29,423
| New | +$890K | 0.05% | 474 |
|
|
2018
Q3 | – | Sell |
-23,972
| Closed | -$767K | – | 896 |
|
|
2018
Q2 | $767K | Buy |
+23,972
| New | +$767K | 0.06% | 431 |
|